UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): October 6, 2011 (July 25, 2011)
BROOKS AUTOMATION, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State
or other jurisdiction of incorporation)
| |
|
|
|
| 0-25434
|
|
04-3040660 |
|
|
|
|
| (Commission File Number)
|
|
(IRS Employer Identification No.) |
| |
|
|
| 15 Elizabeth Drive, Chelmsford, MA
|
|
01824 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code (978) 262-2400.
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
ITEM 2.01. COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.
On July 25, 2011, Brooks Automation, Inc. (“Brooks” or the “Company”) entered into and consummated
the Agreement and Plan of Merger (the “Agreement”) to acquire Nexus Biosystems, Inc. (“Nexus”), a
U.S. based provider of automation solutions and consumables to the life sciences markets,
specifically biobanking and compound sample management. The Company paid, in cash, an aggregate
merger consideration of $79.0 million, which includes $0.8 million of transaction costs incurred by
Nexus, plus an amount equal to the unrestricted cash of Nexus and its subsidiaries as of the close
of business on the business day prior to the closing in the amount of $6.8 million. The liabilities
of Nexus at the time of closing included a $6.0 million obligation payable to former owners of a
business acquired by Nexus in 2010, which was paid by the Company on Nexus’ behalf at the time of
closing.
This Form 8-K/A amends the current report on Form 8-K dated July 27, 2011 to include Item 9.01(a),
Financial Statements of Businesses Acquired, and Item 9.01(b), Pro Forma Financial Information.
Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements of Business Acquired.
The audited financial statements of Nexus Biosystems, Inc. as of and for the year ended December
31, 2010, together with the accompanying Independent Auditors’ Report, are set forth in Exhibit
99.1.
The unaudited financial statements of Nexus Biosystems, Inc. as of June 30, 2011 and for the six
months ended June 30, 2011 and June 30, 2010 are set forth in Exhibit 99.2.
(b) Unaudited Pro Forma Financial Information.
The unaudited pro forma condensed combined financial information for Brooks and Nexus, for the
periods reflected therein, is set forth in Exhibit 99.3.
(c) See the Exhibit Index attached to this Current Report on Form 8-K, which is incorporated herein
by reference.
2